CTRI/2022/10/046524尚未招募3 期
A CLINICAL STUDY TO FIND OUT THE CHANGES INPULMONARY FUNCTION TEST IN ALLERGIC BRONCHIALASTHMA WITH INDIVIDUALISED HOMOEOPATHIC MEDICINE
Dr GEETHU K P0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient with age 18- 60 years of any gender.
- •2. Patients with reduction in FEV1 / FVC Ratio ( below 70 %)
- •3. Patient with increased serum IgE level.
- •4. Patient with signs and symptoms of allergic asthma.
排除标准
- •1. Patients with immune deficiency diseases like AIDS, cancer etc
- •2. Patients with systemic illness that is contraindicated in spirometry (myocardial
- •infarction, pneumothorax , large aneurysm etc).
- •3. Status asthmaticus
- •4. Pregnant and lactating mother
研究者
相似试验
招募中
不适用
on-invasive assessment of lung remodeling in patients with idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) using [11C]-Nintedanib or [18F]-FLT PET imaging.NL-OMON44254Vrije Universiteit90
已完成
不适用
ew pulmonary function assessment using chest X-ray dynamic digital radiographyChronic obstructive pulmonary disease (COPD), In terstitial lung disease (ILD)JPRN-jRCTs042220018Ohkura Noriyuki160
招募中
Unknown
Breath analysis of the patients with few missing teeth after the placement of removable artificial teeth setCTRI/2024/07/071718Dr.Prudhvi Rudraraju
撤回
不适用
Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress SyndromeRespiratory Distress SyndromeNCT01537354University of Michigan
招募中
不适用
A study to evaluate the long-term effect of pulmonary hypertension on prognosis, activities of daily living (ADL), cardiac function and pulmonary function in patients with COPD and IPF, respectively, according to baseline severity of pulmonary hypertension and the efficacy and safety of the Tracleer (bosentan hydrate) tablet for prognosis, activities of daily living, cardiac function and pulmonary function in patients with COPD and IIPs, respectively, according to baseline severity of pulmonary hypertension.Patients with COPD or IPF (WHO functional class II, III or IV), without hypoxia (PaO2 at rest<90mmHg or after 6minutes walk), who provide their informed consent to participate in this study.JPRN-UMIN000004749Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School160